{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T13:00:03Z","timestamp":1779886803789,"version":"3.53.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Genetics"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.cancergen.2012.01.011","type":"journal-article","created":{"date-parts":[[2012,5,2]],"date-time":"2012-05-02T14:00:57Z","timestamp":1335967257000},"page":"156-162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Cytogenetic profile of locally advanced and metastatic schistosoma-related bladder cancer and response to chemotherapy"],"prefix":"10.1016","volume":"205","author":[{"given":"Magdy Sayed","family":"Aly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussein Mostafa","family":"Khaled","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Emara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek D.","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergen.2012.01.011_bib1","unstructured":"National Cancer Institute registry. The national cancer registry newsletter, Ministry of Health and Population, Cairo, Egypt;\u00a02002."},{"key":"10.1016\/j.cancergen.2012.01.011_bib2","first-page":"737","article-title":"Numerical aberrations of chromosomes 7, 9 and 17 in squamous cell and transitional cell cancer of the bladder: a comparative study performed by fluorescence in situ hybridization","volume":"160","author":"Pycha","year":"1998","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.cancergen.2012.01.011_bib3","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1093\/carcin\/21.9.1721","article-title":"Comparison of genetic changes in schistosome-related transitional and squamous bladder cancers using comparative genomic hybridization","volume":"21","author":"Muscheck","year":"2000","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.cancergen.2012.01.011_bib4","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0002-9440(10)64956-5","article-title":"DNA copy number changes in Schistosoma-associated and non-Schistosoma-associated bladder cancer","volume":"156","author":"El-Rifai","year":"2000","journal-title":"Am J Path"},{"issue":"10","key":"10.1016\/j.cancergen.2012.01.011_bib5","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1038\/modpathol.3800177","article-title":"CpG island methylation in Schistosoma- and non-Shistosoma-associated bladder cancer","volume":"17","author":"Gutierrez","year":"2004","journal-title":"Modern Pathology"},{"issue":"5","key":"10.1016\/j.cancergen.2012.01.011_bib6","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S1078-1439(03)00014-0","article-title":"Correlation between p53 mutations and HPV in bilharzial bladder cancer","volume":"21","author":"Khaled","year":"2003","journal-title":"Urol Oncol"},{"issue":"4","key":"10.1016\/j.cancergen.2012.01.011_bib7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1136\/mp.54.4.215","article-title":"What we could do now: molecular pathology of bladder cancer","volume":"54","author":"Knowles","year":"2001","journal-title":"Molecular Pathology"},{"key":"10.1016\/j.cancergen.2012.01.011_bib8","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000227042","article-title":"Intratumoral heterogeneity in DNA ploidy of bladder carcinomas","volume":"49","author":"Sasaki","year":"1992","journal-title":"Oncology"},{"key":"10.1016\/j.cancergen.2012.01.011_bib9","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/cyto.990220407","article-title":"Origins and clinical implications of aneuploidy in early bladder cancer","volume":"22","author":"Shackney","year":"1995","journal-title":"Cytometry"},{"key":"10.1016\/j.cancergen.2012.01.011_bib10","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/BF00211411","article-title":"Flow cytometry versus urinary cytology in the diagnosis and follow-up of bladder tumors: critical review of a 5-year experience","volume":"11","author":"Billerey","year":"1993","journal-title":"World J Urol"},{"key":"10.1016\/j.cancergen.2012.01.011_bib11","first-page":"4658","article-title":"Chromosomal imbalances in noninvasive papillary bladder neoplasms (pTa)","volume":"59","author":"Zhao","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergen.2012.01.011_bib12","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0165-4608(99)00040-0","article-title":"Chromosomal aberrations in Bilharzial bladder cancer as detected by fluorescence in situ hybridization","volume":"114","author":"Aly","year":"1999","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergen.2012.01.011_bib13","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0165-4608(99)00126-0","article-title":"Loss of Y chromosome in bilharzial bladder cancer","volume":"117","author":"Khaled","year":"2000","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergen.2012.01.011_bib14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0165-4608(01)00527-1","article-title":"Chromosomal aberrations in early-stage bilharzial bladder cancer","volume":"132","author":"Aly","year":"2002","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergen.2012.01.011_bib15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000132971","article-title":"Targeted cytogenetic analysis of gastric tumors by in situ hybridization with a set of 12 chromosome-specific DNA probes","volume":"54","author":"Van Dekken","year":"1990","journal-title":"Cytogenet Cell Genet"},{"issue":"18","key":"10.1016\/j.cancergen.2012.01.011_bib16","doi-asserted-by":"crossref","first-page":"4090","DOI":"10.1002\/cncr.24467","article-title":"Phase II trial of sorafenib (BAY43-9006) in patients with advanced urothelial cancer (E1804): a trial of the Eastern Cooperative Oncology Group","volume":"115","author":"Dreicer","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.cancergen.2012.01.011_bib17","doi-asserted-by":"crossref","first-page":"4602","DOI":"10.1200\/JCO.2005.07.757","article-title":"Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer","volume":"23","author":"von der Maase","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cancergen.2012.01.011_bib18","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1002\/cncr.23692","article-title":"Advanced bladder cancer: status of first-line chemotherapy and the search for active agents in the second-line setting","volume":"113","author":"Gallagher","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.cancergen.2012.01.011_bib19","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2005.23.16_suppl.4594","article-title":"A\u00a0single-arm, multicenter, open-label, phase II study of lapatinib as treatment of patients with locally advanced\/metastatic transitional cell carcinoma of the urothelial tract","author":"W\u00fclfing","year":"2005","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1016\/j.cancergen.2012.01.011_bib20","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1442-2042.1997.tb00144.x","article-title":"Correlation of allelic loss of the P53 gene and tumor grade, stage, and malignant progression in bladder cancer","volume":"4","author":"Tsutsumi","year":"1997","journal-title":"Int J Urol"},{"key":"10.1016\/j.cancergen.2012.01.011_bib21","first-page":"2307","article-title":"Chromosomal instability rather than p53 mutation is associated with response to neoadjuvant cisplatin-based chemotherapy in gastric carcinoma","volume":"9","author":"Ott","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cancergen.2012.01.011_bib22","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/jnci\/djh011","article-title":"Circulating DNA microsatellites: molecular determinants of response to biochemotherapy in patients with metastatic melanoma","volume":"96","author":"Taback","year":"2004","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.cancergen.2012.01.011_bib23","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1093\/jnci\/90.19.1473","article-title":"Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas","volume":"90","author":"Cairncross","year":"1998","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.cancergen.2012.01.011_bib24","first-page":"393","article-title":"Radical cystectomy for carcinoma of the bladder, critical evaluation of the results in 1,026 cases","volume":"158","author":"Ghoneim","year":"1997","journal-title":"J\u00a0Urol"},{"issue":"6","key":"10.1016\/j.cancergen.2012.01.011_bib25","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.urolonc.2004.07.015","article-title":"Chromosomal aberrations in Cis and Ta bilharzial bladder cancer: a theory of pathogenesis","volume":"22","author":"Khaled","year":"2004","journal-title":"Urol Oncol"},{"key":"10.1016\/j.cancergen.2012.01.011_bib26","first-page":"545","article-title":"Review of chromosome studies in urological tumors. II. Cytogenetics and molecular genetics of bladder cancer","volume":"151","author":"Sandberg","year":"1994","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.cancergen.2012.01.011_bib27","first-page":"3555","article-title":"Genetic alterations in primary bladder cancers and their metastases","volume":"58","author":"Hovey","year":"1998","journal-title":"Cancer Res"},{"issue":"suppl 10","key":"10.1016\/j.cancergen.2012.01.011_bib28","first-page":"2199","article-title":"Heterogeneity of erbB-2 gene amplification in bladder cancer","volume":"53","author":"Sauter","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergen.2012.01.011_bib29","doi-asserted-by":"crossref","first-page":"826","DOI":"10.2741\/2105","article-title":"Chromosomal deletions in bladder cancer: shutting down pathways","volume":"12","author":"Abraham","year":"2007","journal-title":"Front Biosci"},{"issue":"2","key":"10.1016\/j.cancergen.2012.01.011_bib30","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4149\/neo_2010_02_111","article-title":"Negative prognostic significance of two or more cytogenetic abnormalities in multiple myeloma patients treated with autologous stem cell transplantation","volume":"57","author":"Greslikova","year":"2010","journal-title":"Neoplasma"}],"container-title":["Cancer Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776212000403?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776212000403?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:36:59Z","timestamp":1761896219000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210776212000403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S2210776212000403"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergen.2012.01.011","relation":{},"ISSN":["2210-7762"],"issn-type":[{"value":"2210-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytogenetic profile of locally advanced and metastatic schistosoma-related bladder cancer and response to chemotherapy","name":"articletitle","label":"Article Title"},{"value":"Cancer Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cancergen.2012.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}